The yellow fever 17D vaccine and risk of malignant melanoma in the United States military

The yellow fever 17D vaccine and risk of malignant melanoma in the United States military

Highlights ► We assessed the association between YF 17D and risk of malignant melanoma. ► Population included active US military personnel who received any vaccine. ► No association was found between YF 17D and risk of malignant melanoma in military in the 10 years following vaccination.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Vaccine 2012-06, Vol.30 (30), p.4476-4479
Hauptverfasser: Hodges-Vazquez, Meredith, Wilson, James P, Hughes, Hayley, Garman, Patrick
Format: Artikel
Sprache:eng
Schlagworte:
Adult
Allergy and Immunology
Antigen (tumor-associated)
antigens
Case-Control Studies
Female
Homology
Humans
Logistic Models
Male
Melanoma
Melanoma - epidemiology
Military
Military Personnel
monitoring
Mycobacterium
Nested case–control study
protective effect
risk
Risk Factors
Skin cancer
Smallpox
Studies
Tuberculosis
United States
Vaccination
Vaccines
Vector-borne diseases
Yellow fever
Yellow fever vaccine
Yellow Fever Vaccine - administration & dosage
Yellow fever virus
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Highlights ► We assessed the association between YF 17D and risk of malignant melanoma. ► Population included active US military personnel who received any vaccine. ► No association was found between YF 17D and risk of malignant melanoma in military in the 10 years following vaccination.
ISSN:0264-410X
1873-2518
DOI:10.1016/j.vaccine.2012.04.074